| 0 (0%) | 04-26 18:46 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.02 |
1-year : | 3.27 |
| Resists | First : | 2.58 |
Second : | 2.79 |
| Pivot price | 2.51  |
|||
| Supports | First : | 2.25 |
Second : | 1.87 |
| MAs | MA(5) : | 2.65 |
MA(20) : | 2.5 |
| MA(100) : | 2.83 |
MA(250) : | 2.81 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 81.8 |
D(3) : | 84.8 |
| RSI | RSI(14): 47.2 |
|||
| 52-week | High : | 3.4 | Low : | 2.25 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ASRV ] has closed above bottom band by 48.7%. Bollinger Bands are 63.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.75 - 2.76 | 2.76 - 2.77 |
| Low: | 2.48 - 2.49 | 2.49 - 2.5 |
| Close: | 2.49 - 2.51 | 2.51 - 2.53 |
Mon, 22 Apr 2024
The Colombian Army will proceed with the purchase of additional ASV M1117 vehicles from the United States - Zona Militar
Thu, 21 Mar 2024
FactSet Research Systems: ASV Growth Will Likely Be Weak In FY 2024, Initiate Buy (FDS) - Seeking Alpha
Sat, 02 Mar 2024
Short-term effects of sodium arsenite (AsIII) and sodium arsenate (AsV) on carbohydrate metabolism in the perfused rat ... - ScienceDirect.com
Fri, 29 Dec 2023
No Improved Outcomes for HF Patients With Sleep Apnea Using ASV Breathing Devices - Medpage Today
Thu, 28 Dec 2023
ASV intros new attachments for CTLs and skid steers - Equipment World
Tue, 05 Dec 2023
ASV expands attachment lineup - Total Landscape Care
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 17 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 19.5 (%) |
| Held by Institutions | 35.7 (%) |
| Shares Short | 11 (K) |
| Shares Short P.Month | 11 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.05 |
| Profit Margin | -6.6 % |
| Operating Margin | 18.5 % |
| Return on Assets (ttm) | -0.3 % |
| Return on Equity (ttm) | -2.9 % |
| Qtrly Rev. Growth | 2.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2.64 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 24.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -12.56 |
| PEG Ratio | 0 |
| Price to Book value | 0.41 |
| Price to Sales | 0.94 |
| Price to Cash Flow | 0 |
| Dividend | 0.02 |
| Forward Dividend | 0 |
| Dividend Yield | 1.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|